New York Law Journal: AI and Life Sciences Patents – Separating Myth From Reality
March 20, 2020
O’Melveny partners Lisa Pensabene and Hassen Sayeed, counsel Carolyn Wall, and associate James Yi Li authored this bylined article, which separates myth from the reality of how AI will impact life sciences patent law.
“Fears that AI will replace human inventors contradict the current U.S. patent law framework and ignore the way that drugs are actually discovered,” the authors wrote. “That is not to say, however, that life science patent practitioners should expect to see all concerns about the impact of AI to fade away. Practitioners would do well to prepare—and prepare their clients—for how AI may change the legal landscape with respect to patent obviousness, written description, and enablement.”
Read the full article here.